Council of the European Union decisions on designer drugs
Council of the European Union decisions on designer drugs. Council of the European Union issued a set of decisions on 7 designer drugs to make them subject to control measures and criminal provisions.
List of substances
- paramethoxymethamphetamine (PMMA)
- 2C-I
- 2C-T-2
- 2C-T-7
- 2,4,5-trimethoxyamphetamine (TMA-2)
- benzylpiperazine (BZP)
- mephedrone (4-MMC)
Decisions
- Council Decision 2002/188/JHA of 28 February 2002 concerning control measures and criminal sanctions in respect of the new synthetic drug PMMA
- Council Decision 2003/847/JHA of 27 November 2003 concerning control measures and criminal sanctions in respect of the new synthetic drugs 2C-I, 2C-T-2, 2C-T-7 and TMA-2
Decisions based on Council Decision 2005/387/JHA of 10 May 2005 on the information exchange, risk-assessment and control of new psychoactive substances:
- Council Decision 2008/206/JHA of 3 March 2008 on defining 1-benzylpiperazine (BZP) as a new psychoactive substance which is to be made subject to control measures and criminal provisions
- Council Decision 2010/759/EU of 2 December 2010 on submitting 4-methylmethcathinone (mephedrone) to control measures
Sources
See also
- Designer drugs
- Recreational drug use
- Single Convention on Narcotic Drugs
- Convention on Psychotropic Substances
- European law on drug precursors
- European Monitoring Centre for Drugs and Drug Addiction
External links
- Control measures EMCDDA
- Drugs policy - Adopted legislation European Commission
- Substances and classifications table (31/10/2008) – European Legal Database on Drugs report on all substances controlled in at least one EU country as of 31 October 2008 in XLS format
This article is issued from Wikipedia - version of the 11/26/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.